293(top 100%)
PR articles
21.6K(top 1%)
PR citations
73(top 100%)
PR h-index
81(top 100%)
h-index
358
documents
30.0K
doc citations
5.5K
citing journals
100
times ranked

Publications

300 PR articles • 24,389 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Relational Co‐ordination and Stigma at Work: How Frontline Employees Compensate for Failures in Public Health Systems6.63Citations (PDF)
2Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries
Nature Medicine, 2024, 30, 414-423
39.513Citations (PDF)
3The prevalence of cardiovascular disease risk factors among adults living in extreme poverty
Nature Human Behaviour, 2024, 8, 903-916
10.56Citations (PDF)
4Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data
Global Heart, 2024, 19,
2.75Citations (PDF)
5A simulation-based comparative effectiveness analysis of policies to improve global maternal health outcomes
Nature Medicine, 2023, 29, 1262-1272
39.513Citations (PDF)
6Simulation-based estimates and projections of global, regional and country-level maternal mortality by cause, 1990–2050
Nature Medicine, 2023, 29, 1253-1261
39.529Citations (PDF)
7How systems respond to policies: intended and unintended consequences of COVID-19 lockdown policies in Thailand
Health Policy and Planning, 2022, 37, 292-293
2.85Citations (PDF)
8Digital Education for Health Professionals: An Evidence Map, Conceptual Framework, and Research Agenda4.966Citations (PDF)
9Use of Interrupted Time Series Analysis in Understanding the Course of the Congenital Syphilis Epidemic in Brazil3.029Citations (PDF)
10Grass-roots entrepreneurship complements traditional top-down innovation in lung and breast cancer10.73Citations (PDF)
11The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review4.136Citations (PDF)
12Incidence and prevalence of type 1 diabetes and diabetic ketoacidosis in children and adolescents (0–19 years) in Thailand (2015–2020): A nationwide population-based study3.614Citations (PDF)
13Strengthening Health Systems To Face Pandemics: Subnational Policy Responses To COVID-19 In Latin America
Health Affairs, 2022, 41, 454-462
5.523Citations (PDF)
14Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data
The Lancet Global Health, 2022, 10, e369-e379
14.082Citations (PDF)
15The State of Cardiovascular Disease in G20+ Countries​1.02Citations (PDF)
16Strategic Public-Private Partnerships to Transform Cardiovascular Health1.03Citations (PDF)
17Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data
Diabetes Care, 2022, 45, 1961-1970
6.540Citations (PDF)
18Data Resource Profile: The Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC)5.115Citations (PDF)
19Designing, Developing, Evaluating, and Implementing a Smartphone-Delivered, Rule-Based Conversational Agent (DISCOVER): Development of a Conceptual Framework
JMIR MHealth and UHealth, 2022, 10, e38740
4.931Citations (PDF)
20Conversational Agents in Health Care: Scoping Review of Their Behavior Change Techniques and Underpinning Theory4.939Citations (PDF)
21Patterns of multimorbidity in India: A nationally representative cross-sectional study of individuals aged 15 to 49 years
PLOS Global Public Health, 2022, 2, e0000587
2.228Citations (PDF)
22Multimorbidity and out-of-pocket expenditure for medicines in China and India
BMJ Global Health, 2022, 7, e007724
4.712Citations (PDF)
23Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: A scoping review
PLOS Global Public Health, 2022, 2, e0001099
2.238Citations (PDF)
24Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study
PLoS Medicine, 2022, 19, e1003938
8.524Citations (PDF)
25System dynamics modelling to formulate policy interventions to optimise antibiotic prescribing in hospitals3.116Citations (PDF)
26A global investment framework for the elimination of hepatitis B
Journal of Hepatology, 2021, 74, 535-549
3.683Citations (PDF)
27Impact of non-communicable disease multimorbidity on health service use, catastrophic health expenditure and productivity loss in Indonesia: a population-based panel data analysis study
BMJ Open, 2021, 11, e041870
2.049Citations (PDF)
28Resources management impact on neonatal services performance in the United Kingdom: A system dynamics modelling approach1.92Citations (PDF)
29Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis
BMJ Global Health, 2021, 6, e004042
4.740Citations (PDF)
30The association between mental-physical multimorbidity and disability, work productivity, and social participation in China: a panel data analysis
BMC Public Health, 2021, 21,
3.320Citations (PDF)
31Variation in the Proportion of Adults in Need of Blood Pressure–Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries
Circulation, 2021, 143, 991-1001
25.221Citations (PDF)
32Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis
Lancet Oncology, The, 2021, 22, 341-350
26.063Citations (PDF)
33Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data
PLoS Medicine, 2021, 18, e1003485
8.547Citations (PDF)
34Use of social impact bonds in financing health systems responses to non-communicable diseases: scoping review
BMJ Global Health, 2021, 6, e004127
4.720Citations (PDF)
35Medical imaging and nuclear medicine: a Lancet Oncology Commission
Lancet Oncology, The, 2021, 22, e136-e172
26.0287Citations (PDF)
36Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis2.633Citations (PDF)
37The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults
The Lancet Healthy Longevity, 2021, 2, e340-e351
10.8212Citations (PDF)
38Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis
The Lancet Global Health, 2021, 9, e782-e792
14.0315Citations (PDF)
39Targeting Hypertension Screening in Low‐ and Middle‐Income Countries: A Cross‐Sectional Analysis of 1.2 Million Adults in 56 Countries4.37Citations (PDF)
40Guidance for Health Care Leaders During the Recovery Stage of the COVID-19 Pandemic
JAMA Network Open, 2021, 4, e2120295
6.855Citations (PDF)
41Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults
Lancet, The, 2021, 398, 238-248
52.8134Citations (PDF)
42It takes two to dance the VBHC tango: A multiple case study of the adoption of value-based strategies in Sweden and Brazil
Social Science and Medicine, 2021, 282, 114145
4.322Citations (PDF)
43Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model
The Lancet Global Health, 2021, 9, e1539-e1552
14.047Citations (PDF)
44Non-communicable disease risk factors and management among internal migrant in China: systematic review and meta-analysis
BMJ Global Health, 2021, 6, e003324
4.78Citations (PDF)
45The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis
Lancet Oncology, The, 2021, 22, 1301-1311
26.027Citations (PDF)
46Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis
Lancet Oncology, The, 2021, 22, 1427-1437
26.076Citations (PDF)
47Socioeconomic inequalities in effective service coverage for reproductive, maternal, newborn, and child health: a comparative analysis of 39 low-income and middle-income countries
EClinicalMedicine, 2021, 40, 101103
8.539Citations (PDF)
48Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis
The Lancet Global Health, 2021, 9, e1372-e1379
14.095Citations (PDF)
49Punt Politics as Failure of Health System Stewardship: Evidence from the COVID-19 Pandemic Response in Brazil and Mexico3.048Citations (PDF)
50Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: A cross-sectional study of nationally representative surveys
PLoS Medicine, 2021, 18, e1003841
8.539Citations (PDF)
51The Lancet Commission on diagnostics: transforming access to diagnostics
Lancet, The, 2021, 398, 1997-2050
52.8332Citations (PDF)
52Health priority-setting for official development assistance in low-income and middle-income countries: a Best Fit Framework Synthesis study with primary data from Ethiopia, Nigeria and Tanzania
BMC Public Health, 2021, 21,
3.33Citations (PDF)
53Integrating HIV services and other health services: A systematic review and meta-analysis
PLoS Medicine, 2021, 18, e1003836
8.5112Citations (PDF)
54Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration
PLoS Medicine, 2021, 18, e1003835
8.57Citations (PDF)
55Brexit and Health: A Tragedy of Errors
2021, ,
0Citations (PDF)
56Paediatric Oncology System Integration Tool (POSIT) for the joint analysis of the performance of childhood cancer programs and health systems
Journal of Cancer Policy, 2020, 23, 100208
1.48Citations (PDF)
57Machine learning health-related applications in low-income and middle-income countries: a scoping review protocol
BMJ Open, 2020, 10, e035983
2.09Citations (PDF)
58Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data
The Lancet Global Health, 2020, 8, e840-e849
14.0313Citations (PDF)
59Trends, patterns and health consequences of multimorbidity among South Korea adults: Analysis of nationally representative survey data 2007-20162.937Citations (PDF)
60Analysis of Attained Height and Diabetes Among 554,122 Adults Across 25 Low- and Middle-Income Countries
Diabetes Care, 2020, 43, 2403-2410
6.53Citations (PDF)
61The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis
Lancet Oncology, The, 2020, 21, 1089-1098
26.048Citations (PDF)
62Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis
Lancet Oncology, The, 2020, 21, 1077-1088
26.057Citations (PDF)
63Global hepatitis C elimination: an investment framework23.640Citations (PDF)
64The allocation of US$105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments
The Lancet Global Health, 2020, 8, e1295-e1304
14.060Citations (PDF)
65Progress towards reducing sociodemographic disparities in breastfeeding outcomes in Indonesia: a trend analysis from 2002 to 2017
BMC Public Health, 2020, 20,
3.315Citations (PDF)
66The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion
Lancet, The, 2020, 396, 991-1044
52.8238Citations (PDF)
67Study protocol on Enhanced Primary Healthcare (EnPHC) interventions: a quasi-experimental controlled study on diabetes and hypertension management in primary healthcare clinics1.712Citations (PDF)
68The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia2.619Citations (PDF)
69Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis
European Radiology, 2020, 30, 5560-5577
3.771Citations (PDF)
7012 Lessons learned from the management of the coronavirus pandemic
Health Policy, 2020, 124, 577-580
2.9155Citations (PDF)
71Determinants of healthcare utilisation by migrant workers in the State of Qatar
Health Policy, 2020, 124, 873-880
2.912Citations (PDF)
72Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries
Diabetes Care, 2020, 43, 767-775
6.5141Citations (PDF)
73Innovative financing to fund surgical systems and expand surgical care in low-income and middle-income countries
BMJ Global Health, 2020, 5, e002375
4.748Citations (PDF)
74Evaluation of sex differences in dietary behaviours and their relationship with cardiovascular risk factors: a cross-sectional study of nationally representative surveys in seven low- and middle-income countries
Nutrition Journal, 2020, 19,
3.520Citations (PDF)
75Sustainable care for children with cancer: a Lancet Oncology Commission
Lancet Oncology, The, 2020, 21, e185-e224
26.0294Citations (PDF)
76Should doctors use their judgment? How a system dynamics model elicited knowledge in neonatal care services3.14Citations (PDF)
77On time horizons in health economic evaluations
Health Policy and Planning, 2020, 35, 1237-1243
2.875Citations (PDF)
78Rural and urban differences in health system performance among older Chinese adults: cross-sectional analysis of a national sample2.638Citations (PDF)
79Association between country preparedness indicators and quality clinical care for cardiovascular disease risk factors in 44 lower- and middle-income countries: A multicountry analysis of survey data
PLoS Medicine, 2020, 17, e1003268
8.519Citations (PDF)
80Conversational Agents in Health Care: Scoping Review and Conceptual Analysis4.9439Citations (PDF)
81COVID-19 Response in Latin America0.0186Citations (PDF)
82Surgery and universal health coverage: Designing an essential package for surgical care expansion and scale-up2.923Citations (PDF)
83Hybrid Organizations in Health Systems: The Corporatization of Malaysia’s National Heart Institute1.44Citations (PDF)
84Recruitment and participation of a survey in a public–private primary care setting: experience from the QUALICOPC Malaysia1.72Citations (PDF)
85Leveraging mobile applications in humanitarian crisis to improve health: a case of Syrian women and children refugees in Turkey0.52Citations (PDF)
86Political priority and pathways to scale-up of childhood cancer care in five nations
PLoS ONE, 2019, 14, e0221292
2.431Citations (PDF)
87Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis2.960Citations (PDF)
88Cochrane review: Search strategies to identify observational studies in MEDLINE and EMBASE2.110Citations (PDF)
89The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults
Lancet, The, 2019, 394, 652-662
52.8555Citations (PDF)
90HIV and the growing health burden from noncommunicable diseases in Botswana: modelling study2.926Citations (PDF)
91Brazil's unified health system: the first 30 years and prospects for the future
Lancet, The, 2019, 394, 345-356
52.8782Citations (PDF)
92Health system modelling research: towards a whole-health-system perspective for identifying good value for money investments in health system strengthening
BMJ Global Health, 2019, 4, e001311
4.728Citations (PDF)
93Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries2.933Citations (PDF)
94Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
BMJ Global Health, 2019, 4, e001441
4.75Citations (PDF)
95The political economy of health financing reform in Malaysia
Health Policy and Planning, 2019, 34, 732-739
2.829Citations (PDF)
96Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
Liver International, 2019, 39, 1818-1836
4.154Citations (PDF)
97The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study
PLoS ONE, 2019, 14, e0221944
2.472Citations (PDF)
98PS-065-The global investment case for hepatitis Celimination
Journal of Hepatology, 2019, 70, e39-e40
3.60Citations (PDF)
99Global childhood cancer survival estimates and priority-setting: a simulation-based analysis
Lancet Oncology, The, 2019, 20, 972-983
26.0228Citations (PDF)
100Consumption of Fruits and Vegetables Among Individuals 15 Years and Older in 28 Low- and Middle-Income Countries
Journal of Nutrition, 2019, 149, 1252-1259
3.0117Citations (PDF)
101Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact
Lancet Oncology, The, 2019, 20, 915-923
26.059Citations (PDF)
102Hypertension screening, awareness, treatment, and control in India: A nationally representative cross-sectional study among individuals aged 15 to 49 years
PLoS Medicine, 2019, 16, e1002801
8.5185Citations (PDF)
103Variation in health system performance for managing diabetes among states in India: a cross-sectional study of individuals aged 15 to 49 years
BMC Medicine, 2019, 17,
7.581Citations (PDF)
104How the health-seeking behaviour of pregnant women affects neonatal outcomes: findings of system dynamics modelling in Pakistan
BMJ Global Health, 2019, 4, e001242
4.718Citations (PDF)
105A multilevel neo‐institutional analysis of infection prevention and control in English hospitals: coerced safety culture change?
Sociology of Health and Illness, 2019, 41, 1138-1158
2.413Citations (PDF)
106Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys
PLoS Medicine, 2019, 16, e1002751
8.5272Citations (PDF)
107Estimating the total incidence of global childhood cancer: a simulation-based analysis
Lancet Oncology, The, 2019, 20, 483-493
26.0339Citations (PDF)
108The long run impact of early childhood deworming on numeracy and literacy: Evidence from Uganda3.115Citations (PDF)
109The impact of the Family Medicine Model on patient satisfaction in Turkey: Panel analysis with province fixed effects
PLoS ONE, 2019, 14, e0210563
2.416Citations (PDF)
110The impact of user charges on health outcomes in low-income and middle-income countries: a systematic review
BMJ Global Health, 2019, 3, e001087
4.750Citations (PDF)
111Systematic review of evidence on public health in the Democratic People’s Republic of Korea
BMJ Global Health, 2019, 4, e001133
4.75Citations (PDF)
112Democratizing innovation through grass-roots entrepreneurship: lessons from efforts to address the opioid epidemic in the United States
BMJ Global Health, 2019, 4, e002079
4.76Citations (PDF)
113Financial performance of English NHS trusts and variation in clinical outcomes: a longitudinal observational study
BMJ Open, 2019, 9, e021854
2.09Citations (PDF)
114Health diplomacy through health entrepreneurship: using hackathons to address Palestinian-Israeli health concerns
BMJ Global Health, 2019, 4, e001548
4.721Citations (PDF)
115Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008–16
Lancet Oncology, The, 2019, 20, e672-e684
26.019Citations (PDF)
116Artificial intelligence and algorithmic bias: implications for health systems2.9417Citations (PDF)
117The prevalence of concurrently raised blood glucose and blood pressure in India
Journal of Hypertension, 2019, 37, 1822-1831
2.38Citations (PDF)
118Childhood cancer burden: a review of global estimates
Lancet Oncology, The, 2019, 20, e42-e53
26.0381Citations (PDF)
119Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas
Lancet Public Health, The, 2019, 4, e89-e96
19.5147Citations (PDF)
120Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission23.6481Citations (PDF)
121Effects of expanding a non-contributory health insurance scheme on out-of-pocket healthcare spending by the poor in Turkey
BMJ Global Health, 2019, 4, e001540
4.718Citations (PDF)
122Digital Education in Health Professions: The Need for Overarching Evidence Synthesis4.9154Citations (PDF)
123Mobile Digital Education for Health Professions: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration4.9138Citations (PDF)
124Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
Diabetes Care, 2018, 41, 963-970
6.5941Citations (PDF)
125Action to address the household economic burden of non-communicable diseases
Lancet, The, 2018, 391, 2047-2058
52.8218Citations (PDF)
126Diabetes and Hypertension in India
JAMA Internal Medicine, 2018, 178, 363
10.8323Citations (PDF)
127Brazil’s Family Health Strategy: factors associated with programme uptake and coverage expansion over 15 years (1998–2012)
Health Policy and Planning, 2018, 33, 368-380
2.868Citations (PDF)
128Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report
Lancet, The, 2018, 391, 1391-1454
52.81,050Citations (PDF)
129Addressing the Unknowns of Antimicrobial Resistance: Quantifying and Mapping the Drivers of Burden
Clinical Infectious Diseases, 2018, 66, 612-616
5.418Citations (PDF)
130Artificial intelligence, machine learning and health systems2.9462Citations (PDF)
131Early experience of universal health coverage in Turkey on access to health services for the poor: regression kink design analysis2.914Citations (PDF)
132Transition to universal primary health care coverage in Brazil: Analysis of uptake and expansion patterns of Brazil’s Family Health Strategy (1998-2012)
PLoS ONE, 2018, 13, e0201723
2.449Citations (PDF)
133Articulating citizen participation in national anti-microbial resistance plans: a comparison of European countries0.37Citations (PDF)
134Non-technical health care quality and health system responsiveness in middle-income countries: a cross-sectional study in China, Ghana, India, Mexico, Russia, and South Africa2.928Citations (PDF)
135The role of eLearning in health management and leadership capacity building in health system: a systematic review3.537Citations (PDF)
136Quantifying drivers of antibiotic resistance in humans: a systematic review
Lancet Infectious Diseases, The, 2018, 18, e368-e378
15.7283Citations (PDF)
137A systematic analysis of UK cancer research funding by gender of primary investigator
BMJ Open, 2018, 8, e018625
2.024Citations (PDF)
138The Brazilian health system at crossroads: progress, crisis and resilience
BMJ Global Health, 2018, 3, e000829
4.7408Citations (PDF)
139Estimating the burden of antimicrobial resistance: a systematic literature review4.2455Citations (PDF)
140Geographic and sociodemographic variation of cardiovascular disease risk in India: A cross-sectional study of 797,540 adults
PLoS Medicine, 2018, 15, e1002581
8.581Citations (PDF)
141Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition
Lancet, The, 2018, 391, 1108-1120
52.8186Citations (PDF)
142Health Systems in Transition: Professional Identity Work in the Context of Shifting Institutional Logics7.6120Citations (PDF)
143Large Reductions In Amenable Mortality Associated With Brazil’s Primary Care Expansion And Strong Health Governance
Health Affairs, 2017, 36, 149-158
5.576Citations (PDF)
144Prioritizing problems in and solutions to homecare safety of people with dementia: supporting carers, streamlining care
BMC Geriatrics, 2017, 17,
3.415Citations (PDF)
145Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries3.5192Citations (PDF)
146The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study22.6676Citations (PDF)
147Investments in cancer research awarded to UK institutions and the global burden of cancer 2000–2013: a systematic analysis
BMJ Open, 2017, 7, e013936
2.022Citations (PDF)
148Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries
BMJ Global Health, 2017, 2, e000243
4.798Citations (PDF)
149Effects of economic downturns on child mortality: a global economic analysis, 1981–2010
BMJ Global Health, 2017, 2, e000157
4.725Citations (PDF)
150Innovative financing instruments for global health 2002–15: a systematic analysis
The Lancet Global Health, 2017, 5, e720-e726
14.048Citations (PDF)
151Quasi-experimental study designs series—paper 7: assessing the assumptions3.7118Citations (PDF)
152Quasi-experimental study designs series–paper 12: strengthening global capacity for evidence synthesis of quasi-experimental health systems research3.713Citations (PDF)
153Quasi-experimental study designs series—paper 4: uses and value3.7210Citations (PDF)
154Dynamic modeling approaches to characterize the functioning of health systems: A systematic review of the literature
Social Science and Medicine, 2017, 194, 160-167
4.347Citations (PDF)
155eLearning for health system leadership and management capacity building: a protocol for a systematic review
BMJ Open, 2017, 7, e017050
2.06Citations (PDF)
156Diabetes in sub-Saharan Africa: from clinical care to health policy22.6434Citations (PDF)
157Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis
The Lancet Global Health, 2017, 5, e772-e781
14.049Citations (PDF)
158National Drug Stockout Risks and the Global Fund Disbursement Process for Procurement4.552Citations (PDF)
159Effect of primary health care reforms in Turkey on health service utilization and user satisfaction2.846Citations (PDF)
160Unemployment and HIV mortality in the countries of the Organisation for Economic Co-operation and Development: 1981–2009
JRSM Open, 2017, 8,
0.810Citations (PDF)
161User–fee–removal improves equity of children’s health care utilization and reduces families’ financial burden: evidence from Jamaica2.913Citations (PDF)
162Prioritizing medication safety in care of people with cancer: clinicians’ views on main problems and solutions2.99Citations (PDF)
163Fukushima after the Great East Japan Earthquake: lessons for developing responsive and resilient health systems2.940Citations (PDF)
164Ebola research funding: a systematic analysis, 1997–20152.967Citations (PDF)
165Shifting chronic disease management from hospitals to primary care in Estonian health system: analysis of national panel data2.917Citations (PDF)
166Health system resilience: Lebanon and the Syrian refugee crisis2.9159Citations (PDF)
167Innovative financing for HIV response in sub–Saharan Africa2.927Citations (PDF)
168Aligning values and outcomes in priority–setting for health2.99Citations (PDF)
169Factors influencing physicians’ choice of workplace: systematic review of drivers of attrition and policy interventions to address them2.935Citations (PDF)
170Integration of antenatal care services with health programmes in low– and middle–income countries: systematic review2.944Citations (PDF)
171Expansion of health insurance in Moldova and associated improvements in access and reductions in direct payments2.96Citations (PDF)
172Kangaroo mother care: a systematic review of barriers and enablers2.2194Citations (PDF)
173The power of integration: radiotherapy and global palliative care1.49Citations (PDF)
174Preventing delayed diagnosis of cancer: clinicians’ views on main problems and solutions2.925Citations (PDF)
175Identification of priorities for improvement of medication safety in primary care: a PRIORITIZE study3.124Citations (PDF)
176Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis
Lancet, The, 2016, 388, 684-695
52.8160Citations (PDF)
177PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries’ Budgeted Funds, 2004–14
Health Affairs, 2016, 35, 847-855
5.511Citations (PDF)
178Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries22.6129Citations (PDF)
179Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study
BMJ Open, 2016, 6, e009656
2.043Citations (PDF)
180Effects of economic crises on population health outcomes in Latin America, 1981–2010: an ecological study
BMJ Open, 2016, 6, e007546
2.026Citations (PDF)
181Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa
Aids, 2016, 30, 2341-2350
2.542Citations (PDF)
182Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997–20133.84Citations (PDF)
183Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997–2013
EBioMedicine, 2016, 3, 180-190
9.935Citations (PDF)
184Estimating the true global burden of mental illness
Lancet Psychiatry,the, 2016, 3, 171-178
18.82,021Citations (PDF)
185Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration3.7239Citations (PDF)
186Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997–20132.711Citations (PDF)
187Unemployment and prostate cancer mortality in the OECD, 1990–20090.912Citations (PDF)
188Unemployment, public–sector health care expenditure and HIV mortality: An analysis of 74 countries, 1981–20092.99Citations (PDF)
189Women and Health: the key for sustainable development
Lancet, The, 2015, 386, 1165-1210
52.8374Citations (PDF)
190Unemployment, public-sector health-care spending and breast cancer mortality in the European Union: 1990-20090.321Citations (PDF)
191Changes in government spending on healthcare and population mortality in the European union, 1995–2010: a cross-sectional ecological study2.251Citations (PDF)
192Innovative financing for late-stage global health research and development: the Global Health Investment Fund
International Health, 2015, , ihv067
2.46Citations (PDF)
193Unemployment, Government Healthcare Spending, and Cerebrovascular Mortality, Worldwide 1981–2009: An Ecological Study6.822Citations (PDF)
194Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997–2013
EBioMedicine, 2015, 2, 1193-1199
9.916Citations (PDF)
195Strengthening health systems in low-income countries by enhancing organizational capacities and improving institutions3.5100Citations (PDF)
196The effect of economic downturns on maternal mortality among pregnancies with abortive outcomes in 81 countries, 1981–20101.92Citations (PDF)
197Government Health Care Spending and Child Mortality
Pediatrics, 2015, 135, e887-e894
4.733Citations (PDF)
198Achieving Effective Universal Health Coverage And Diagonal Approaches To Care For Chronic Illnesses
Health Affairs, 2015, 34, 1514-1522
5.560Citations (PDF)
199Expanding global access to radiotherapy
Lancet Oncology, The, 2015, 16, 1153-1186
26.0947Citations (PDF)
200Stopping tuberculosis: a biosocial model for sustainable development
Lancet, The, 2015, 386, 2354-2362
52.896Citations (PDF)
201Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997–2010
JRSM Open, 2015, 6,
0.83Citations (PDF)
202Health-system reform and universal health coverage in Latin America
Lancet, The, 2015, 385, 1230-1247
52.8581Citations (PDF)
203Overcoming social segregation in health care in Latin America
Lancet, The, 2015, 385, 1248-1259
52.8145Citations (PDF)
204Social determinants of health, universal health coverage, and sustainable development: case studies from Latin American countries
Lancet, The, 2015, 385, 1343-1351
52.8292Citations (PDF)
205Unemployment, public-sector healthcare expenditure and colorectal cancer mortality in the European Union: 1990–20091.915Citations (PDF)
206Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis
PLoS ONE, 2015, 10, e0127199
2.4207Citations (PDF)
207Effect of health system reforms in Turkey on user satisfaction2.913Citations (PDF)
208Investments in sexually transmitted infection research, 1997–2013: a systematic analysis of funding awarded to UK institutions2.93Citations (PDF)
209Offline eLearning for undergraduates in health professions: A systematic review of the impact on knowledge, skills, attitudes and satisfaction2.986Citations (PDF)
210Infectious disease research investments follow colonial ties: questionable ethics
International Health, 2014, 6, 74-76
2.414Citations (PDF)
211Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997–2010
BMJ Open, 2014, 4, e004129
2.021Citations (PDF)
212Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997–20102.26Citations (PDF)
213Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997–2010
JRSM Open, 2014, 5,
0.82Citations (PDF)
214Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening
Health Policy and Planning, 2014, 29, 986-997
2.861Citations (PDF)
215Health impact of external funding for HIV, tuberculosis and malaria: systematic review
Health Policy and Planning, 2014, 29, 650-662
2.820Citations (PDF)
216Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-20103.221Citations (PDF)
217Investments in respiratory infectious disease research 1997–2010: a systematic analysis of UK funding
BMJ Open, 2014, 4, e004600
2.018Citations (PDF)
218Funding Infectious Disease Research: A Systematic Analysis of UK Research Investments by Funders 1997–2010
PLoS ONE, 2014, 9, e105722
2.413Citations (PDF)
219Universal health coverage in Turkey: enhancement of equity
Lancet, The, 2013, 382, 65-99
52.8369Citations (PDF)
220Global health initiative investments and health systems strengthening: a content analysis of global fund investments3.5103Citations (PDF)
221UK investments in global infectious disease research 1997–2010: a case study15.7109Citations (PDF)
222Infectious disease research investments: Systematic analysis of immunology and vaccine research funding in the UK
Vaccine, 2013, 31, 5930-5933
3.23Citations (PDF)
223Integrating tuberculosis and <scp>HIV</scp> services in low‐ and middle‐income countries: a systematic review2.0127Citations (PDF)
224Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997–2010
BMJ Open, 2013, 3, e003362
2.062Citations (PDF)
225Financing Essential HIV Services: A New Economic Agenda
PLoS Medicine, 2013, 10, e1001567
8.538Citations (PDF)
226How Trustworthiness is Assessed in Health Care: A Sensemaking Perspective
Journal of Change Management, 2013, 13, 159-178
2.010Citations (PDF)
227The Uptake of Integrated Perinatal Prevention of Mother-to-Child HIV Transmission Programs in Low- and Middle-Income Countries: A Systematic Review
PLoS ONE, 2013, 8, e56550
2.463Citations (PDF)
228Global Fund Financing of Tuberculosis Services Delivery in Prisons
Journal of Infectious Diseases, 2012, 205, S274-S283
3.89Citations (PDF)
229An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries
Health Policy and Planning, 2012, 27, 649-657
2.848Citations (PDF)
230Guidance for Evidence-Informed Policies about Health Systems: Linking Guidance Development to Policy Development
PLoS Medicine, 2012, 9, e1001186
8.5101Citations (PDF)
231Investing in Improved Performance of National Tuberculosis Programs Reduces the Tuberculosis Burden: Analysis of 22 High-Burden Countries, 2002–2009
Journal of Infectious Diseases, 2012, 205, S284-S292
3.819Citations (PDF)
232Guidance for Evidence-Informed Policies about Health Systems: Rationale for and Challenges of Guidance Development
PLoS Medicine, 2012, 9, e1001185
8.598Citations (PDF)
233Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change
Health Policy and Planning, 2012, 27, iv54-iv61
2.8182Citations (PDF)
234Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review
PLoS Medicine, 2012, 9, e1001358
8.538Citations (PDF)
235Negative health system effects of Global Fund's investments in AIDS, tuberculosis and malaria from 2002 to 2009: systematic review
JRSM Short Reports, 2012, 3, 1-14
0.713Citations (PDF)
236Health systems, systems thinking and innovation
Health Policy and Planning, 2012, 27, iv4-iv8
2.8189Citations (PDF)
237Eliminating Tuberculosis and Tuberculosis-HIV Co-Disease in the 21st Century: Key Perspectives, Controversies, Unresolved Issues, and Needs
Journal of Infectious Diseases, 2012, 205, S141-S146
3.817Citations (PDF)
238Technologies for global health
Lancet, The, 2012, 380, 507-535
52.8345Citations (PDF)
239Is operational research delivering the goods? The journey to success in low-income countries15.776Citations (PDF)
240Innovative financing for health: what is truly innovative?
Lancet, The, 2012, 380, 2044-2049
52.881Citations (PDF)
241Global Fund investments in harm reduction from 2002 to 20093.48Citations (PDF)
242Tuberculosis and Tuberculosis/HIV/AIDS-Associated Mortality in Africa: The Urgent Need to Expand and Invest in Routine and Research Autopsies
Journal of Infectious Diseases, 2012, 205, S340-S346
3.842Citations (PDF)
243Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
Journal of Infectious Diseases, 2012, 205, S147-S158
3.8172Citations (PDF)
244The effects of Global Fund financing on health governance in Brazil3.57Citations (PDF)
245Mobile phone messaging for facilitating self-management of long-term illnesses
The Cochrane Library, 2012, 2012,
2.4482Citations (PDF)
246Mobile phone messaging for preventive health care
The Cochrane Library, 2012, 2012,
2.4229Citations (PDF)
247Funding for malaria control 2006–2010: A comprehensive global assessment
Malaria Journal, 2012, 11,
2.765Citations (PDF)
248Implementing the Global Plan to Stop TB, 2011–2015 – Optimizing Allocations and the Global Fund’s Contribution: A Scenario Projections Study
PLoS ONE, 2012, 7, e38816
2.419Citations (PDF)
249Adoption of Rapid Diagnostic Tests for the Diagnosis of Malaria, a Preliminary Analysis of the Global Fund Program Data, 2005 to 2010
PLoS ONE, 2012, 7, e43549
2.426Citations (PDF)
250Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs
Journal of Infectious Diseases, 2012, 205, S228-S240
3.8156Citations (PDF)
251Integrating Prevention of Mother-to-Child HIV Transmission Programs to Improve Uptake: A Systematic Review
PLoS ONE, 2012, 7, e35268
2.452Citations (PDF)
252Telephone Consultation for Improving Health of People Living with or at Risk of HIV: A Systematic Review
PLoS ONE, 2012, 7, e36105
2.415Citations (PDF)
253Towards an improved investment approach for an effective response to HIV/AIDS
Lancet, The, 2011, 377, 2031-2041
52.8443Citations (PDF)
254HPTN 052 and the future of HIV treatment and prevention
Lancet, The, 2011, 378, 226
52.87Citations (PDF)
255Effect of Investment in Malaria Control on Child Mortality in Sub-Saharan Africa in 2002–2008
PLoS ONE, 2011, 6, e21309
2.439Citations (PDF)
256Indicators Measuring the Performance of Malaria Programs Supported by the Global Fund in Asia, Progress and the Way Forward
PLoS ONE, 2011, 6, e28932
2.47Citations (PDF)
257Building a Durable Response to HIV/AIDS: Implications for Health Systems1.834Citations (PDF)
258Viewpoint: Scientific dogmas, paradoxes and mysteries of latent <i>Mycobacterium tuberculosis</i> infection2.055Citations (PDF)
259Global Fund financing of public–private mix approaches for delivery of tuberculosis care2.023Citations (PDF)
260Tuberculosis in prisons in sub-Saharan Africa – the need for improved health services, surveillance and control
Tuberculosis, 2011, 91, 173-178
2.077Citations (PDF)
261Sex, drugs and economic behaviour in Russia: A study of socio-economic characteristics of high risk populations3.415Citations (PDF)
262Integration of priority population, health and nutrition interventions into health systems: systematic review
BMC Public Health, 2011, 11,
3.332Citations (PDF)
263The Global Fund's resource allocation decisions for HIV programmes: addressing those in need3.622Citations (PDF)
264Positive spill‐over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi3.631Citations (PDF)
265Critical Interactions Between the Global Fund–Supported HIV Programs and the Health System in Ghana1.843Citations (PDF)
266Health systems strengthening: a common classification and framework for investment analysis
Health Policy and Planning, 2011, 26, 316-326
2.869Citations (PDF)
267Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality2.264Citations (PDF)
268Sexual and reproductive health activities in HIV programmes: can we monitor progress?3.14Citations (PDF)
269Scaling Up Towards International Targets for AIDS, Tuberculosis, and Malaria: Contribution of Global Fund-Supported Programs in 2011–2015
PLoS ONE, 2011, 6, e17166
2.417Citations (PDF)
270Long-Term Costs and Health Impact of Continued Global Fund Support for Antiretroviral Therapy
PLoS ONE, 2011, 6, e21048
2.434Citations (PDF)
271Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
PLoS ONE, 2011, 6, e25310
2.484Citations (PDF)
272A conceptual and analytical approach to comparative analysis of country case studies: HIV and TB control programmes and health systems integration
Health Policy and Planning, 2010, 25, i21-i31
2.822Citations (PDF)
273A systematic review of the evidence on integration of targeted health interventions into health systems2.8186Citations (PDF)
274Health systems, communicable diseases and integration
Health Policy and Planning, 2010, 25, i4-i20
2.890Citations (PDF)
275Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia
Health Policy and Planning, 2010, 25, 283-291
2.828Citations (PDF)
276Integration of targeted health interventions into health systems: a conceptual framework for analysis
Health Policy and Planning, 2010, 25, 104-111
2.8321Citations (PDF)
277HIV epidemics and prevention responses in Asia and Eastern Europe: lessons to be learned?
Aids, 2010, 24, S86-S94
2.520Citations (PDF)
278Interactions between critical health system functions and HIV/AIDS, tuberculosis and malaria programmes2.817Citations (PDF)
279Health-system strengthening and tuberculosis control
Lancet, The, 2010, 375, 2169-2178
52.8103Citations (PDF)
280Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action
Lancet, The, 2010, 375, 2179-2191
52.8119Citations (PDF)
281Expansion of cancer care and control in countries of low and middle income: a call to action
Lancet, The, 2010, 376, 1186-1193
52.8686Citations (PDF)
282Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments
Lancet, The, 2010, 376, 1409-1416
52.852Citations (PDF)
283An assessment of interactions between global health initiatives and country health systems
Lancet, The, 2009, 373, 2137-2169
52.8453Citations (PDF)
284Promoting Country Ownership and Stewardship of Health Programs: The Global Fund Experience1.826Citations (PDF)
285Prevention of HIV/AIDS among injecting drug users in Russia: Opportunities and barriers to scaling-up of harm reduction programmes
Health Policy, 2008, 85, 162-171
2.944Citations (PDF)
286Public-private partnership in cord blood banking
BMJ: British Medical Journal, 2008, 336, 642-644
0.150Citations (PDF)
287Resistance to implementing policy change: the case of Ukraine2.232Citations (PDF)
288Market Failure and the Poverty of New Drugs in Maternal Health
PLoS Medicine, 2008, 5, e22
8.5118Citations (PDF)
289Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery2.245Citations (PDF)
290Introducing a complex health innovation—Primary health care reforms in Estonia (multimethods evaluation)
Health Policy, 2006, 79, 79-91
2.966Citations (PDF)
291The unfinished journey from Semashko to Bismarck: health reform in Central Asia from 1991 to 2006
Central Asian Survey, 2006, 25, 419-440
1.530Citations (PDF)
292Risk factors for pulmonary tuberculosis in Russia: case-control study0.1143Citations (PDF)
293Health-care system frailties and public health control of communicable disease on the European Union's new eastern border
Lancet, The, 2004, 363, 1389-1392
52.875Citations (PDF)
294Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries2.464Citations (PDF)
295The quality of care in outpatient primary care in public and private sectors in Malaysia2.82Citations (PDF)
296On discount rates for economic evaluations in global health2.8124Citations (PDF)
297Burden of Mental, Neurological, Substance Use Disorders and Self-Harm in North America: A Comparative Epidemiology of Canada, Mexico, and the United States
Canadian Journal of Psychiatry, 0, , 070674371989016
2.922Citations (PDF)
298Universal health care in middle-income countries: Lessons from four countries2.934Citations (PDF)
299Scope, Characteristics, Behavior Change Techniques, and Quality of Conversational Agents for Mental Health and Well-Being: Systematic Assessment of Apps4.919Citations (PDF)
300Conversational Agents in Health Care: Expert Interviews to Inform the Definition, Classification, and Conceptual Framework4.918Citations (PDF)